Jillian Sunderland has previously received funding from Social Sciences and Humanities Research Council (SSHRC) Grant and the Ontario Graduate Scholarship (OGS) Award. University of Toronto provides ...
This summer, I got cultural whiplash. As a child of the ’90s and early 2000s, I grew up with my mother’s and grandmother’s generations’ fight for legal and workplace equality helping shed social ...
Catheter-associated urinary tract infections (CAUTIs) are a significant cause of morbidity and mortality among hospitalized patients, prompting the implementation of various strategies to reduce their ...
Keersten Fitzgerald does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
This year’s report provides the external sector assessment of 30 of the world’s largest economies on the basis of their 2024 data. Global current account balances in 2024 widened significantly. Staff ...
A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback